Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · Real-Time Price · USD
2.200
-0.090 (-3.93%)
At close: Feb 21, 2025, 4:00 PM
2.180
-0.020 (-0.91%)
After-hours: Feb 21, 2025, 7:54 PM EST

Stereotaxis Market Cap

Stereotaxis has a market cap or net worth of $185.56 million as of February 21, 2025. Its market cap has decreased by -4.40% in one year.

Market Cap
185.56M
Enterprise Value
181.03M
1-Year Change
-4.40%
Ranking
Category
Stock Price
$2.20

Market Cap Chart

Since August 12, 2004, Stereotaxis's market cap has increased from $183.10M to $185.56M, an increase of 1.34%. That is a compound annual growth rate of 0.06%.

History

DateMarket Cap% Change
Feb 21, 2025185.60M-3.93%
Dec 31, 2024193.20M36.54%
Dec 29, 2023141.50M-8.65%
Dec 30, 2022154.90M-66.50%
Dec 31, 2021462.40M23.27%
Dec 31, 2020375.10M6.26%
Dec 31, 2019353.00M474.92%
Dec 31, 201861.40M237.36%
Dec 29, 201718.20M28.17%
Dec 30, 201614.20M-10.69%
Dec 31, 201515.90M-47.52%
Dec 31, 201430.30M-47.49%
Dec 31, 201357.70M215.30%
Dec 31, 201218.30M-55.90%
Dec 30, 201141.50M-76.45%
Dec 31, 2010176.20M-2.22%
Dec 31, 2009180.20M19.97%
Dec 31, 2008150.20M-63.64%
Dec 31, 2007413.10M27.11%
Dec 29, 2006325.00M49.56%
Dec 30, 2005217.30M991.96%
Dec 31, 200419.90M-89.13%
View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 799.36B
UnitedHealth Group 421.02B
Johnson & Johnson 388.52B
Novo Nordisk 370.84B
AbbVie 356.88B
Abbott Laboratories 234.12B
AstraZeneca 227.07B
Merck & Co. 224.48B
Market Cap Rankings